A Feasibility Study of Uncontrolled Donation After Circulatory Death

  • Research type

    Research Study

  • Full title

    A Feasibility Study of Uncontrolled Donation After Circulatory Death: a Combined Cohort and Qualitative Study

  • IRAS ID

    324623

  • Contact name

    Dominic Summers

  • Contact email

    dms39@cam.ac.uk

  • Sponsor organisation

    Cambridge University Hospitals

  • Clinicaltrials.gov Identifier

    TF093 , NHS Blood and Transplant Fund; PO118622, Royal College of Surgeons Sir Roy and Lady Calne

  • Duration of Study in the UK

    2 years, 0 months, 0 days

  • Research summary

    There are an estimated 3 deaths a day related to the shortage of donor organs. ‘Standard’ donation pathways from intensive care units only provide around 1500 donors per year in the UK. Unlike in other countries, there is no uncontrolled donation after circulatory death (uDCD) pathway in the UK to enable donation for those who die following out-of-hospital cardiac arrest (OHCA). uDCD is challenging to implement as, following death, organs have to be preserved rapidly before they are irreversibly damaged; and this has to be done in a manner that is acceptable for donor families.
    This is a feasibility study of kidney transplantation following uDCD donation, with three key workstreams: 1. Design
    and evaluation of an effective and acceptable resuscitation, donation and kidney transplant pathway for patients with
    out-of-hospital cardiac arrest. We aim to recover, transplant and evaluate kidneys from 5 uDCD donors in Cambridge. Eligible patients would be those under 60 years who have a witnessed OHCA; we estimate that there will be 23 such potential donors a year. Recovered kidneys will be offered to recipients in Cambridge and at the Royal Free Hospital. Kidney recipients will receive routine post-transplant follow-up 2. Qualitative assessment, using semi-structured interviews of potential donor families, to evaluate the experience and acceptability of the donation pathway for relatives, and to identify ways in which it could be improved. 3. Piloting a new test (using RNA sequencing of kidney biopsies) to determine whether kidneys recovered from donors are safe to transplant.
    The study is funded by the Addenbrooke’s Charitable Trust, NHS Blood and Transplant, and the Royal College of
    Surgeons of England. Confirmation that uDCD is feasible, safe and acceptable to families in the UK would support a large-scale UK implementation study, and potentially increase UK donation rates by 25%.

  • REC name

    East Midlands - Leicester Central Research Ethics Committee

  • REC reference

    23/EM/0257

  • Date of REC Opinion

    20 Dec 2023

  • REC opinion

    Further Information Favourable Opinion